公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2012 | Novel sorafenib derivatives (SC-40, SC-43 and SC-60) show better anti-tumor effects than sorafenib in hepatocellular carcinoma through SHP-1/STAT3-mediated signaling pathway | Tai, Wei-Tien; Shiau, Chung-Wai; Cheng, Ann-Lii; Chen, Pel-Jer; Chen, Kuen-Feng; 陳培哲 | Cancer Res. | 0 | 0 | |
2014 | A sorafenib derivative and novel SHP-1 agonist, SC-59, acts synergistically with radiotherapy in hepatocellular carcinoma cells through inhibition of STAT3 | CHAO YUAN HUANG ; Tai, Wei-Tien; Hsieh, Chi-Ying; Hsu, Wan-Mai; Lai, Ying-Jiun; Chen, Li-Ju; Shiau, Chung-Wai; Chen, Kuen-Feng | Cancer letters | 19 | 17 | |
2013 | Sorafenib enhances radiation-induced apoptosis in hepatocellular carcinoma by inhibiting STAT3 | CHAO YUAN HUANG ; Lin, Chen-Si; Tai, Wei-Tien; Hsieh, Chi-Ying; Shiau, Chung-Wai; ANN-LII CHENG ; Chen, Kuen-Feng | International journal of radiation oncology, biology, physics | 43 | 43 | |